Johnson & Johnson said on Friday it resumed the limited market release of its Varipulse heart device in the United States ...

Shares of Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eleven research firms that are presently covering the stock, ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Irhythm Technologies (IRTC – Research Report), Vir ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Rua Dr. Diogo de Faria, 1087 – 9º andar – Vila Clementino 04037-003 São Paulo/SP - Brasil E-mail: [email protected] ...

sharewise wants to provide you with the best news and tools for Rhythm Pharmaceuticals, so we directly link to the best financial data sources.

Shares of Rhythm Pharmaceuticals, Inc. (RYTM) have gained 0.3% over the past four weeks to close the last trading session at $56.52, but there could still be a solid upside left in the stock if ...

Rhythm Pharmaceuticals, Inc. (RYTM) shares soared 5.5% in the last trading session to close at $57.52. The move was backed by solid volume with far more shares changing hands than in a normal session.